| Current Price | $2.46 | Mkt Cap | $578.8M |
|---|---|---|---|
| Open | $2.36 | P/E Ratio | 0.00 |
| Prev. Close | $2.46 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.34 - $2.58 | Volume | 8,690,296 |
| 52-Wk Range | $1.83 - $29.15 | Avg. Daily Vol. | 23,912,558 |
| Current Price | $2.46 | Mkt Cap | $578.8M |
|---|---|---|---|
| Open | $2.36 | P/E Ratio | 0.00 |
| Prev. Close | $2.46 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.34 - $2.58 | Volume | 8,690,296 |
| 52-Wk Range | $1.83 - $29.15 | Avg. Daily Vol. | 23,912,558 |
The best Bull and Bear pitches based on recency and number of recommendations.
Targeted tests might do well in short term but it is bound to disappear as the industry moves toward whole sequence diagnostics.
Read the most recent pitches from players about NVTA.
Recs
thecolonel79
(64.66)
Submitted: 8/26/2022 12:00:26 PM :
Start Price:
$24.35
NYSE:NVTA Score:
-96.66
Finally getting serious about making money.
Recs
leaderoftheback
(55.13)
Submitted: 11/27/2021 9:43:50 AM :
Start Price:
$10.95
NYSE:NVTA Score:
-58.64
November '21; current trade at $18 and trending down. Uncertain of long-term prospects but most risk should be out at $11 start, as that is just slightly above old (more sensible) support levels, though sales have grown significantly since.
Recs
draber
(< 20)
Submitted: 10/12/2021 11:01:37 AM :
Start Price:
$26.34
NYSE:NVTA Score:
-73.19
I purchased this stock because I feel that it is the BEST opportunity in Biotechnology for the expansion of diagnostic testing for inherited diseases, cancers etc to the general public and medical professionals PLUS it is currently at a bargain price @ $26.49
Find the members with the highest scoring picks in NVTA.
FinanceGuy58 (63.18) Score: +476.70
The Score Leader is the player with the highest score across all their picks in NVTA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| chipotlepickle | 87.33 | 4/20/2016 |
|
1Y | $10.77 | -76.93% | +71.16% | +148.08 | 0 Comment | |
| LazyHarlequin | 93.63 | 5/8/2019 |
|
5Y | $20.03 | -87.59% | +24.44% | +112.04 | 1 Comment | |
| jdgrn01 | < 20 | 2/26/2020 |
|
3Y | $20.70 | -88.00% | +14.19% | +102.18 | 1 Comment | |
| Capitalism | 73.50 | 11/18/2019 |
|
5Y | $18.26 | -86.39% | +15.11% | +101.51 | 1 Comment | |
| Philhi | 66.09 | 12/20/2021 |
|
5Y | $16.75 | -85.16% | -20.53% | +64.63 | 0 Comment | |
| baf72167 | < 20 | 12/21/2021 |
|
5Y | $16.61 | -85.04% | -21.61% | +63.43 | 0 Comment | |
| AllFunkedUp | < 20 | 12/30/2021 |
|
3Y | $15.90 | -84.37% | -24.80% | +59.57 | 0 Comment | |
| cashsage | 99.94 | 2/3/2022 |
|
5Y | $10.79 | -76.97% | -20.23% | +56.74 | 0 Comment | |
|
chammond55 | 96.02 | 4/27/2022 |
|
5Y | $5.09 | -51.18% | -13.88% | +37.30 | 0 Comment |
| markkinney1988 | 22.21 | 8/15/2022 |
|
1Y | $4.47 | -44.41% | -15.40% | +29.00 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
